A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines

This study has been completed.
Sponsor:
Collaborator:
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00076063
First received: January 13, 2004
Last updated: May 3, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given